24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publication dates

Lymphoma Industry, March 2015 Market Reports from Top Publishers

You might be interested in: flow cytometry, hematology, therapeutics, cancer, melanoma, medical equipment, t-cell lymphoma, leukemia, nuclear medicine, pap smear, breast cancer, prostate cancer, atherosclerosis, colorectal cancer, pancreatic cancer.


 
1-10 of about 200 reports for Lymphoma

Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

Non-Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Non-Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Non-Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

Acute Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Acute Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Acute Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

Burkitt Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Burkitt Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Burkitt Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

Follicular Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Follicular Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Follicular Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

Mantle Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Mantle Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Mantle Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

Peripheral T-Cell Lymphomas (PTCL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Peripheral T-Cell Lymphomas (PTCL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Peripheral T-Cell Lymphomas (PTCL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and ...

T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

About 1 500 reports for Lymphoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • April 2014
    28 pages
  • Cancer  

  • United States  

    North America  

View report >

23 Companies for Lymphoma

Read our Company Profiles

Celgene Corp.

United States

Novartis Inc.

Switzerland

Pharmacyclics Inc.

United States

Seattle Genetics Inc.

United States

Bristol-Myers Squibb Co.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.